BCM
THC icon

Bayesian Capital Management’s Tenet Healthcare THC Stock Holding History

Bayesian Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,300
Closed -$229K – 795
2025
Q2 		$229K Buy
+1,300
New +$196K 0.04% 432
2024
Q1 		– Sell
-3,847
Closed -$291K – 1118
2023
Q4 		$291K Buy
+3,847
New +$244K 0.03% 521
2023
Q2 		– Sell
-8,300
Closed -$493K – 1062
2023
Q1 		$493K Buy
8,300
+4,200
+102% +$233K 0.06% 394
2022
Q4 		$200K Sell
4,100
-8,800
-68% -$407K 0.03% 602
2022
Q3 		$665K Buy
12,900
+1,900
+17% +$113K 0.13% 211
2022
Q2 		$578K Buy
+11,000
New +$766K 0.11% 291
2021
Q3 		– Sell
-3,956
Closed -$265K – 543
2021
Q2 		$265K Buy
+3,956
New +$245K 0.07% 311
2020
Q4 		– Sell
-18,400
Closed -$451K – 664
2020
Q3 		$451K Buy
+18,400
New +$470K 0.11% 245
2020
Q2 		– Sell
-10,000
Closed -$144K – 779
2020
Q1 		$144K Buy
+10,000
New +$287K 0.03% 630
2019
Q4 		– Sell
-10,000
Closed -$221K – 748
2019
Q3 		$221K Sell
10,000
-43,100
-81% -$918K 0.04% 427
2019
Q2 		$1.1M Buy
53,100
+37,800
+247% +$871K 0.23% 127
2019
Q1 		$441K Buy
+15,300
New +$378K 0.08% 317
2018
Q3 		– Sell
-18,200
Closed -$611K – 792
2018
Q2 		$611K Sell
18,200
-23,600
-56% -$734K 0.14% 220
2018
Q1 		$1.01M Buy
+41,800
New +$832K 0.26% 120
2017
Q3 		– Sell
-34,000
Closed -$658K – 633
2017
Q2 		$658K Buy
+34,000
New +$593K 0.24% 144

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bayesian Capital Management's THC Position: Q3 2025 in Review

Bayesian Capital Management sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 1,300 shares — an estimated $229K sold.

Bayesian Capital Management first reported a position in THC in Q2 2017 and held it in 15 quarters. The position peaked at $1.1M in Q2 2019. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Bayesian Capital Management reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 1,300 Tenet Healthcare shares in Q3 2025, an estimated $229K.
  • Bayesian Capital Management first reported a position in Tenet Healthcare in Q2 2017 and held it in 15 quarters.
  • Bayesian Capital Management's Tenet Healthcare position peaked at $1.1M in Q2 2019.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.